Top
OR2G2 has not been detected as a mutational cancer driver

OR2G2
Ensembl id ENSG00000177489
Mutated samples
Coding Sequence 88 (1.3%)
Protein Affecting 56 (0.8%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all OR2G2 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Cutaneous melanoma No 32 20 5.42
Lung adenocarcinoma No 15 12 3.07
Lung squamous cell carcinoma No 8 5 2.87
Bladder carcinoma No 3 3 3.06
Stomach adenocarcinoma No 5 3 1.86
Small cell lung carcinoma No 3 3 4.35
Renal clear cell carcinoma No 4 2 0.48
Uterine corpus endometrioid carcinoma No 3 2 0.87
Head and neck squamous cell carcinoma No 5 2 0.53
Breast carcinoma No 3 1 0.09
Neuroblastoma No 1 1 0.48
Colorectal adenocarcinoma No 1 1 0.44
Glioblastoma multiforme No 3 1 0.26
Hepatocarcinoma No 1 0 0.00
Chronic lymphocytic leukemia No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence